# Four Versus Six Cycles of Pemetrexed/Platinum for MPM

> **NCT02497053** · PHASE2 · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 70 (estimated)

## Conditions studied

- Malignant Pleural Mesothelioma

## Interventions

- **DRUG:** pemetrexed/platinum chemotherapy
- **DRUG:** Pemetrexed/platinum chemotherapy

## Key facts

- **NCT ID:** NCT02497053
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-06
- **Primary completion:** 2016-06
- **Final completion:** —
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2015-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02497053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02497053, "Four Versus Six Cycles of Pemetrexed/Platinum for MPM". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02497053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*